The percentage of high FGF9 level in LNCAFs was substantially higher in intestinal-type GC compared with diffused and mixed–type GC (Fig. 5k, 45.6% vs 21.7%, P < 0.01). This evidence concerns the gene FGF9 and gastric cancer.